logo
Plus   Neg
Share
Email

Lilly : Empagliflozin Reduces Risk Of Cardiovascular Death Or Hospitalization For Heart Failure

Boehringer Ingelheim and Eli Lilly and Co. (LLY) said that Empagliflozin met primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in the EMPEROR-Reduced Phase III trial in adults with and without diabetes.

The study results demonstrated superiority with empagliflozin (10 mg) compared to placebo in reducing the risk for the composite of cardiovascular death or hospitalization due to heart failure, when added to standard of care. Overall, the safety profile was similar to the known safety profile of empagliflozin, the company said in a statement.

Empagliflozin is an oral, once daily, highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor and the first type 2 diabetes medicine to include cardiovascular death risk reduction data in its label in several countries.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Vegpro International is recalling Fresh Attitude baby spinach citing potential to be contaminated with Salmonella, according to the U.S. Food and Drug Administration. The recall involves Fresh Attitude baby spinach of 5oz with best before dates of December 4 & 5; and 11oz with best before date of December 4. Startups Airbnb Inc. and DoorDash Inc. are planning for higher-than-expected valuation ranges for their initial public offerings, the Wall Street Journal reported citing people familiar with the matter. San Francisco-based home rental platform Airbnb is planning to target a range of around $30 billion to $33 billion, higher than the $30 billion it had been expected earlier. U.S. auto safety regulator has opened an investigation into about 115,000 Tesla electric vehicles over a front suspension safety issue. The probe covers 2015 through 2017 Model S sedans and 2016 through 2017 Model X SUVs. The investigation comes after Tesla reportedly started a recall over the issue for vehicles in China.
Follow RTT